ORBIMED ADVISORS LLC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1055951 New York, NY

Position in HRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$7,853,552

-$14,941,479 QoQ

Shares Held

9,816,940

+50.7% QoQ

Ownership

5.17%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 52% Shared 0% None 48%

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	EWTX	Edgewise Therapeutics, Inc.	15,518,492	$630,516,329
2	ELVN	Enliven Therapeutics, Inc.	6,776,632	$343,914,074
3	MBX	MBX Biosciences, Inc.	3,428,736	$189,266,227
4	GPCR	Structure Therapeutics Inc.	2,209,400	$118,578,498
5	SION	Sionna Therapeutics, Inc.	2,555,877	$112,433,029
6	CRVS	Corvus Pharmaceuticals, Inc.	7,165,006	$107,045,189
7	AVBP	ArriVent BioPharma, Inc.	3,027,328	$105,169,374
8	ARGX	Argenx SE	92,880	$86,171,277

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,853,552	9,816,940	+50.7%	Shares	Defined	2026-05-15
2024-06-30	$22,795,031	6,512,866	-35.6%	Shares	Defined	2024-08-14
2024-03-31	$28,008,993	10,111,550	+70.6%	Shares	Defined	2024-05-15
2023-12-31	$10,078,604	5,928,591	+638.6%	Shares	Defined	2024-02-14
2023-09-30	$826,781	802,700	0.0%	Shares	Sole	2023-11-14
2023-06-30	$931,132	802,700	0.0%	Shares	Sole	2023-08-14
2023-03-31	$1,212,077	802,700	-28.5%	Shares	Sole	2023-05-15
2022-09-30	$4,739,060	1,123,000	-5.8%	Shares	Sole	2022-11-14
2020-12-31	$25,231,379	1,191,846	0.0%	Shares	Sole	2021-02-16
2020-09-30	$17,663,157	1,191,846	+80.5%	Shares	Sole	2020-11-16
2020-06-30	$9,714,778	660,420	+22.9%	Shares	Sole	2020-08-14
2020-03-31	$6,309,310	537,420	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.